# Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD – FDA Inspections

Source: https://www.keypedia.com/companies/jubilant-cadista-pharmaceuticals-inc/bf3fdb52-1211-4c3c-8e41-659d9e4e13f9

> Inspection records and compliance data for Jubilant Cadista Pharmaceuticals, Inc. in Salisbury, Maryland. 7 FDA inspections on record, last inspected February 28, 2020.

---

## Details

- Name: Jubilant Cadista Pharmaceuticals, Inc.
- FEI Number: 1000513046
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK, REPACK
- Address Line 1: 207 Kiley Dr
- City: Salisbury
- State: Maryland
- Zip Code: 21801
- Country Name: United States
- Address: 207 Kiley Dr, Salisbury, Maryland 21801, United States
- Country: United States

## Related Documents

- [483 - Jubilant Cadista Pharmaceuticals, Inc. - 2025-01-15](https://www.keypedia.com/records/483/jubilant-cadista-pharmaceuticals-inc/17fffb31-9369-447f-88f9-03a0e7265a40) — source: FDA, date: January 15, 2025
- [483 - Jubilant Cadista Pharmaceuticals, Inc. - 2020-02-28](https://www.keypedia.com/records/483/jubilant-cadista-pharmaceuticals-inc/fdf3097d-13b9-416c-ba5e-0b1cc12c2ece) — source: FDA, date: February 28, 2020
- FDA Inspection 1120136 - Jubilant Cadista Pharmaceuticals, Inc. - 2020-02-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 28, 2020
- [FDA Inspection 1120136 - Jubilant Cadista Pharmaceuticals, Inc. - 2020-02-28](https://www.keypedia.com/records/fda_inspections/jubilant-cadista-pharmaceuticals-inc/53d5483f-7bb8-477d-87e8-7e8ef9b5e346) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 28, 2020
- [FDA Inspection 940733 - Jubilant Cadista Pharmaceuticals, Inc. - 2015-08-07](https://www.keypedia.com/records/fda_inspections/jubilant-cadista-pharmaceuticals-inc/61646c48-445a-4b8e-a7b7-6b8d0e753a5f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 7, 2015
- FDA Inspection 888209 - Jubilant Cadista Pharmaceuticals, Inc. - 2014-07-08 — classification: No Action Indicated (NAI), source: FDA, date: July 8, 2014
- FDA Inspection 842669 - Jubilant Cadista Pharmaceuticals, Inc. - 2013-08-01 — classification: No Action Indicated (NAI), source: FDA, date: August 1, 2013
- FDA Inspection 774268 - Jubilant Cadista Pharmaceuticals, Inc. - 2012-04-05 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 5, 2012
- [FDA Inspection 715587 - Jubilant Cadista Pharmaceuticals, Inc. - 2011-03-23](https://www.keypedia.com/records/fda_inspections/jubilant-cadista-pharmaceuticals-inc/ccf41e68-c202-482c-9eb0-3cd6c9e73349) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 23, 2011
- FDA Inspection 624796 - Jubilant Cadista Pharmaceuticals, Inc. - 2009-10-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 29, 2009

## Related Companies

- [Pfizer, Inc.](https://www.keypedia.com/companies/pfizer-inc/4b87fbf2-bec7-4fde-adf0-4207cd7d93ff)
- [Impax Laboratories, LLC.](https://www.keypedia.com/companies/impax-laboratories-llc/7d8ef88a-fa0d-491d-b7f5-600a09806c0d)
- [High Chemical Company, Div of National Generic Distributors](https://www.keypedia.com/companies/high-chemical-company-div-of-national-generic-distributors/beda0a12-91e3-4246-8bed-a915d42bf6b6)
- [Pharmasol Corporation](https://www.keypedia.com/companies/pharmasol-corporation/7961d42d-8409-45eb-8448-c0f2729ef17c)
- [SGS Chemical Solutions Laboratories Inc.](https://www.keypedia.com/companies/sgs-chemical-solutions-laboratories-inc/972c1151-b936-417c-8168-828eae7cd65d)
- [ULTRAtab Laboratories, Inc.](https://www.keypedia.com/companies/ultratab-laboratories-inc/5455d350-8084-4833-9610-a069ea634da7)
- [Inotiv Inc](https://www.keypedia.com/companies/inotiv-inc/be017b67-b3f0-402d-8a03-b124ca114fa6)
- [PLZ Corp](https://www.keypedia.com/companies/plz-corp/c12286c0-ab29-4ea7-82c7-e402764afab2)
- [William A. Gahl, MD, PhD](https://www.keypedia.com/companies/william-a-gahl-md-phd/8c7e9558-5b83-407b-8d44-a0c934c9c84e)
- [Ahmed Kaldun Nossuli M.D., Principal Investigator](https://www.keypedia.com/companies/ahmed-kaldun-nossuli-md-principal-investigator/abed3af2-8f50-4693-99cf-ca14db6168d8)

## Related Officers

- [Roseline N. Boateng](https://www.keypedia.com/people/roseline-n-boateng/81c4fa2a-1f0b-4e13-ba45-39ca7a07d3b3)
- [Tamecia D Fields](https://www.keypedia.com/people/tamecia-d-fields/20cb0e06-1ad6-46e3-adee-ea7ed33bf4d6)
- [Investigator](https://www.keypedia.com/people/pushpa-s-jayasekara/cfd7d22f-b4c2-4002-ae18-b5435815d27d)
- [FDA_PERSONNEL](https://www.keypedia.com/people/avinash-ghumatkar/9d95e31c-5acb-4e2c-a54a-a39f155bb1ba)
